A 1927nm laser that deliberately doesn't go deep. It treats what sits at the surface — sun spots, dullness, uneven tone — and skips the recovery that comes with reaching further down.
ReVive is non-ablative — nothing is removed during treatment. Its 1927nm wavelength is absorbed so strongly by water that the energy stays in the epidermis, treating surface pigment and letting it shed over about a week. One to three days of visible recovery instead of five to ten. The trade: it doesn't reach the dermis, so it won't do texture, scarring, or laxity.
Most laser marketing treats depth as a virtue — deeper is stronger, stronger is better. That's true if the problem is deep. A lot of what bothers people isn't.
Sun spots, dullness, uneven tone, early photodamage: these live in the outermost layers. A device that reaches into the dermis to treat them is doing more damage than the problem requires, and charging you a week of recovery for the privilege.
Skin is largely water. How strongly a wavelength is absorbed by water determines how far it travels before its energy is spent.
1927nm sits at a strong water absorption peak — considerably stronger than the wavelengths used for dermal resurfacing. The energy is consumed in the outermost layers and simply doesn't reach further.
The fractional handpiece creates microscopic zones of treated tissue in the epidermis. Over the following days that tissue is carried upward as the skin turns over, shedding as light bronzing and fine flaking, while healthy epidermis replaces it.
Non-ablative means nothing is removed at the time of treatment. The shedding happens afterward, on the skin's own schedule — which is why recovery is short and why the result appears over a week rather than immediately.
Improvement is incremental. A single session produces visible brightening, but the result is built across a series — that's the nature of a superficial treatment, and it's the honest trade for the short recovery. Anyone promising dramatic transformation from one non-ablative session is selling something else.
They aren't competing. Erbium and CO2 are resurfacing devices for texture and structural change. ReVive is a brightening device. Choosing between them means deciding what's actually bothering you.
Staying superficial and producing less thermal trauma means lower post-inflammatory hyperpigmentation risk than ablative resurfacing. That's a real advantage in deeper skin types.
Lower risk is not no risk. Any device putting heat into pigmented skin can provoke pigmentary change, and deeper Fitzpatrick types are treated conservatively, at longer intervals, with strict sun protection — and sometimes with a picosecond device instead.
This treats pigment caused largely by sun. Treating it and then returning to unprotected exposure produces the same pigment again, usually within a season.
Daily broad-spectrum SPF isn't aftercare here — it's the maintenance protocol. Patients who commit to it hold their result. Patients who don't are back where they started.
Active infection or inflammatory skin condition in the treatment area. Recent isotretinoin — timing discussed at assessment.
Anyone who won't use sun protection through the shedding phase. Treated skin is more vulnerable to pigmentary change, and this is the most common way a good result goes wrong.
And anyone whose actual concern is texture, scarring, wrinkles, or laxity. A superficial device will not address those. No number of sessions changes it, and being told so at consultation is cheaper than finding out at session four.
The useful thing about a device this specific is that it makes the assessment easy. Either the concern lives at the surface, in which case this is the right tool and the recovery is genuinely short — or it doesn't, in which case no amount of it will help and something else is the answer. That's a clearer conversation than most laser consultations.
What is the ReVive thulium laser?
A 1927nm non-ablative fractional laser made by Rohrer. The wavelength is absorbed very strongly by water, which keeps its energy in the outermost layers of skin rather than letting it travel into the dermis. It treats what lives at the surface — sun spots, dullness, uneven tone, early photodamage — and does so with a fraction of the recovery that ablative resurfacing requires. Non-ablative means no tissue is removed at the time of treatment; the treated cells shed over the following week as the epidermis turns over.
How is it different from erbium or CO2?
Depth and mechanism. Erbium and CO2 are ablative — they remove tissue, reach into the dermis, and drive collagen remodelling, which is why they produce more change and require more recovery. The 1927nm wavelength stays superficial and removes nothing directly. It is a brightening and surface pigment device rather than a resurfacing device, and it should be chosen for what it does rather than treated as a weaker version of something else.
How much downtime is there?
Typically one to three days of redness followed by light bronzing and fine sloughing as treated tissue sheds, with the full shedding process taking around a week. Most patients are comfortable with makeup within a few days. That is considerably shorter than ablative resurfacing, which is the main practical reason to choose it.
Is it safe for darker skin tones?
It carries lower post-inflammatory hyperpigmentation risk than ablative resurfacing, because it stays superficial and produces less thermal trauma. That is a genuine advantage, but lower risk is not no risk — any device delivering heat into pigmented skin can provoke pigmentary change. Deeper Fitzpatrick types are assessed individually, treated conservatively, and in some cases better served by a picosecond device instead.
How many sessions are needed?
Typically three to five, spaced four to six weeks apart. Because the treatment is superficial, each session produces incremental rather than dramatic change, and the result is built cumulatively. A single session produces visible brightening but not a finished result.
Will it treat my melasma?
Cautiously, and it is not the first choice. Melasma is heat-sensitive and can rebound darker after thermal treatment, and much of the pigment sits deeper than a superficial device reaches. Picosecond laser, which fragments melanin photoacoustically rather than by heating it, is the primary approach here, alongside topical management and strict sun avoidance.
Who should not have this treatment?
Anyone with active infection or an inflammatory skin condition in the treatment area, or recent isotretinoin use. Anyone unable to commit to sun protection during the shedding phase, since treated skin is more vulnerable to pigmentary change. And anyone whose actual concern is texture, scarring, wrinkles, or laxity — a superficial device will not address any of those, and no number of sessions changes that.
Can it be combined with other pigment treatments?
Yes. Superficial and deep pigment are different problems, and combining a picosecond device with superficial thulium treatment addresses both across a structured series. Whether that is warranted depends on what the assessment finds — some patients need only one.
That question decides whether this is the right device. Dr. Mortazavi will tell you either way — including when something else fits better.
4667 MacArthur Blvd, Suite 310 — Newport Beach, CA 92660
(949) 568-7544 — info@plumpmedicalspa.com
Tuesday – Saturday, 10am – 6pm